Explicyte is a family brand of specialty preclinical services launched by ImmuSmol, a bordeaux-based company. The first brand, Explicyte Immune-Oncology offers preclinical contract research services in immuno-oncology.
Explicyte Immuno-Oncology currently offers to test innovative cancer immunotherapies in vivo, using syngeneic mouse tumor models treated with immune checkpoint inhibitors (eg. anti-CTLA-4 and anti-PD1/PD-L1 antibodies). In addition, Explicyte is setting up an in vitro platform for the identification and optimization of novel immunomodulators. Equipped with high-content analysis technologies, the platform focuses on live phenotypic screening in co-cultures of immune and cancer cells, as well as molecular cell-based assays for the assessment of immune checkpoint inhibitors.
|
|
|
|
|
11-50 employees
View all Explicyte employees
|
|
|
Biotechnology
|
|
|
$1M–$5M
|
|
|
+1-415-555-0199
|
|
|
229 Cours de l'Argonne, Bordeaux, Nouvelle-Aquitaine 33000, FR
|
|
|
None
|
|
|
Cro, Oncology, Service Provider, Immuno-Oncology, In Vitro And In Vivo, Preclinical Research Services
|
Explicyte headquarters is located at 229 Cours de l'Argonne, Bordeaux, Nouvelle-Aquitaine 33000, FR.
Explicyte generates an estimated $1M–$5M annually, based on industry analysis and publicly available market data.
You can contact Explicyte by calling +1-415-555-0199.
Explicyte headquarters is located at 229 Cours de l'Argonne, Bordeaux, Nouvelle-Aquitaine 33000, FR.
Explicyte generates an estimated $1M–$5M annually, based on industry analysis and publicly available market data.
You can contact Explicyte by calling +1-415-555-0199.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.